Recent events
Recent events tied to this brand in public sources.
Back to profile5 entries
2021
UPL and Chr. Hansen announce strategic collaboration on microbial biosolutions
UPL announced a long-term strategic collaboration with Chr. Hansen to develop microbial-based biosolutions, including biostimulants and biopesticides. UPL will research opportunities and commercialize the products through its distribution network, while Chr. Hansen will design biological products using its microbial capabilities.
2021
Chr. Hansen launches The Probiotics Institute
Chr. Hansen launched The Probiotics Institute, an online platform providing science-based information about probiotics and the human microbiome for healthcare professionals and B2B customers globally.
2020
Chr. Hansen agrees to acquire Jennewein Biotechnologie
Chr. Hansen Holding A/S entered into an agreement to acquire all shares of Jennewein Biotechnologie GmbH, a company described as a leading player in the HMO market.
2020
Chr. Hansen agrees to acquire UAS Laboratories
Chr. Hansen Holding A/S entered into an agreement with the owners of UAS Laboratories to acquire 100% of the Wisconsin-based company, which specializes in clinically documented probiotics.
2019
EIB signs €120 million financing agreement with Chr. Hansen
The European Investment Bank signed a €120 million lending agreement with Chr. Hansen. Chr. Hansen will use the financing to boost research and development in food cultures and enzymes, and health and nutrition.